https://www.selleckchem.com/products/nmd670.html
The main important finding in the present study was that patients having ≥3 risk alleles were associated with higher risk of VTE recurrence compared to those having ≤2 risk alleles (the reference group) (HR 2.5, 95% CI 1.48-4.21) ( = 0.001). Patients with GRS ≥ 3 had a significantly shorter time recurrence free survival (43.07 months) compared to the low risk group of patients with GRS (0-2) ( 0.001). GRS model could be an effective and useful model in risk stratification of VTE patients, and genetic risk profiling of VTE patients c